naltrexone has been researched along with Shock in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, FJ; Hu, DY; Liu, LM; Lu, RQ; Pan, XK | 1 |
| Martin, WR; McNicholas, LF | 1 |
| Amir, S | 1 |
| Ludbrook, J; Ventura, S | 1 |
| Chanmugam, AS; Ezenkwele, U; Hengeller, M | 1 |
| Craft, RM; Dykstra, LA | 1 |
| Fanselow, MS | 1 |
1 review(s) available for naltrexone and Shock
| Article | Year |
|---|---|
New and experimental therapeutic roles for naloxone and related opioid antagonists.
Topics: Alcohol Deterrents; Animals; Bipolar Disorder; Blood Pressure; Brain Ischemia; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Respiration; Schizophrenia; Shock; Spinal Injuries | 1984 |
1 trial(s) available for naltrexone and Shock
| Article | Year |
|---|---|
New and experimental therapeutic roles for naloxone and related opioid antagonists.
Topics: Alcohol Deterrents; Animals; Bipolar Disorder; Blood Pressure; Brain Ischemia; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Respiration; Schizophrenia; Shock; Spinal Injuries | 1984 |
6 other study(ies) available for naltrexone and Shock
| Article | Year |
|---|---|
Subclass opioid receptors associated with the cardiovascular depression after traumatic shock and the antishock effects of its specific receptor antagonists.
Topics: Animals; Blood Pressure; Cardiovascular System; Enkephalin, Leucine; Femur; Free Radicals; GABA Modulators; Hemodynamics; Models, Statistical; Naltrexone; Narcotic Antagonists; Pentobarbital; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Shock; Time Factors | 2005 |
Naloxone improves, and morphine exacerbates, experimental shock induced by release of endogenous histamine by compound 48/80.
Topics: Animals; Central Nervous System; Endorphins; Histamine; Male; Mice; Mice, Inbred ICR; Morphine; Naloxone; Naltrexone; p-Methoxy-N-methylphenethylamine; Shock | 1984 |
The decompensatory phase of acute hypovolaemia in rabbits involves a central delta 1-opioid receptor.
Topics: Animals; Benzylidene Compounds; Blood Pressure; Cardiac Output; Enkephalin, Leucine; Hemodynamics; Hemorrhage; Naltrexone; Narcotic Antagonists; Rabbits; Receptors, Opioid, delta; Shock | 1994 |
Development of rhabdomyolysis after rapid opioid detoxification with subcutaneous naltrexone maintenance therapy.
Topics: Adolescent; Gastrointestinal Hemorrhage; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Mallory-Weiss Syndrome; Naltrexone; Narcotic Antagonists; Rhabdomyolysis; Shock; Time Factors; Vomiting | 2000 |
Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzodiazepines; Benzomorphans; Drug Interactions; Drug Tolerance; Ethylketocyclazocine; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Nociceptors; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Saimiri; Shock; Time Factors | 1992 |
Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress analgesia.
Topics: Analgesia; Animals; Avoidance Learning; Behavior, Animal; Conditioning, Classical; Endorphins; Fear; Formaldehyde; Models, Biological; Motor Activity; Naloxone; Naltrexone; Nociceptors; Sensory Thresholds; Shock; Stress, Physiological | 1986 |